Pharmaceutical Solutions
Showing 1 - 25 of 3,362
SARS-CoV-2, COVID-19, Mouthwashes Trial in Jeddah (Distilled Water, 1% Povidone Iodine (PVP-I), 1.5% Hydrogen Peroxide (H2O2))
Completed
- SARS-CoV-2
- +7 more
- Distilled Water
- +5 more
-
Jeddah, Saudi ArabiaAlhamra TETAMMAN clinic (PHC)
Jul 18, 2022
Infertility, Female Trial in Cairo (Epifasi: Human chorionic gonadotrophin, Pregnyl: Human chorionic gonadotrophin)
Completed
- Infertility, Female
- Epifasi: Human chorionic gonadotrophin
- Pregnyl: Human chorionic gonadotrophin
-
Cairo, EgyptGenuine Research Center GRC
Oct 22, 2020
Women Exposed to Rimegepant During Pregnancy
Active, not recruiting
- Migraine
- Rimegepant
- +2 more
-
Research Triangle Park, North CarolinaResearch Triangle Institute d/b/a RTI Health Solutions
Feb 24, 2022
Hepatic Ascites Trial in Shibin Al Kawm (Oral standard diuretics therapy, Hypertonic saline solution, Etilefrine)
Completed
- Hepatic Ascites
- Oral standard diuretics therapy
- +2 more
-
Shibīn Al Kawm, Menoufiya, EgyptNational liver institute- menoufiya university
Mar 2, 2021
Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via
Completed
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled NO delivered via INOpulse DS-C Device
- Placebo delivered via INOpulse DS-C Device
-
Jasper, Alabama
- +42 more
Jul 13, 2022
Migraine, With or Without Aura Trial in United States (Rimegepant)
Completed
- Migraine, With or Without Aura
-
Birmingham, Alabama
- +97 more
Dec 15, 2022
Acute Migraine Trial in United States (Vazegepant (BHV-3500))
Completed
- Acute Migraine
- Vazegepant (BHV-3500)
-
Huntsville, Alabama
- +66 more
Feb 1, 2022
Alzheimer, Mild Cognitive Impairment Trial in United States (Florbetapir F 18 PET Scan)
Active, not recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Florbetapir F 18 PET Scan
-
Anaheim, California
- +76 more
Sep 21, 2022
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Worldwide (Fasinumab, Naproxen, Fasinumab-matching )
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- +3 more
-
Mesa, Arizona
- +138 more
Oct 18, 2022
Hydration Trial in Kent (Control Group, Oral Rehydration Solution 1, Oral Rehydration Solution 2)
Recruiting
- Hydration
- Control Group
- +3 more
-
Kent, OhioKent State University
Dec 14, 2022
Metabolic Ketoacidosis, Ketoacidemia, Acetonemia Trial in Tunis (Sodium chloride 0.9% (SC), Ringer lactate (RL))
Recruiting
- Metabolic Ketoacidosis
- +3 more
- Sodium chloride 0.9% (SC)
- Ringer lactate (RL)
-
Tunis, TunisiaAhlem Trifi
Apr 11, 2023
Presbyopia, Near Vision, Miosis Trial in China (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic
Not yet recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Wenzhou, Zhejiang, China
- +18 more
Sep 19, 2023
Esophageal Squamous Cell Carcinoma Trial in China (1% Lugol's iodine solution, 5% Lugol's iodine solution)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- 1% Lugol's iodine solution
- 5% Lugol's iodine solution
-
Ankang, Shaanxi, China
- +5 more
Sep 25, 2023
Post-SOPHrology Cancer Patients' anxieTY Report
Terminated
- Cancer
- Questionnaires
-
Saint-Priest-en-Jarez, FranceInstitut de Cancérologie Lucien Neuwirth
Feb 7, 2022
Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,
Recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Chandler, Arizona
- +1 more
Mar 2, 2023
Degenerative Disc Disease Trial in Australia, United States (Rexlemestrocel-L, Rexlemestrocel-L + HA Mixture, Placebo)
Completed
- Degenerative Disc Disease
- Rexlemestrocel-L
- +2 more
-
Birmingham, Alabama
- +47 more
Sep 22, 2022
Androgenetic Alopecia Trial in East Melbourne, Pascoe Vale South (prostaglandin F2a analogue in vehicle solution high dose,
Recruiting
- Androgenetic Alopecia
- prostaglandin F2a analogue in vehicle solution high dose
- +3 more
-
East Melbourne, Victoria, Australia
- +1 more
Dec 20, 2022
Heart Transplantation Trial in Berlin, Gießen, München (Custodiol-N, Custodiol)
Active, not recruiting
- Heart Transplantation
-
Berlin, Germany
- +2 more
Sep 8, 2023
Hepatic Encephalopathy Trial (Branched-chain amino acids (BCAA), enriched solution (Aminoleban) and L-ornithine L-aspartate
Not yet recruiting
- Hepatic Encephalopathy
- Branched-chain amino acids (BCAA), enriched solution (Aminoleban) and L-ornithine L-aspartate (LOLA)
- Branched-chain amino acids (BCAA), enriched solution (Aminoleban)
- (no location specified)
Sep 9, 2022
Fatty Liver Trial in United States (Group 1 NRPT, Group 2 NRPT, Group 3 Placebo)
Completed
- Fatty Liver
- Group 1 NRPT
- +2 more
-
Hialeah, Florida
- +8 more
Oct 23, 2020
Sepsis, Septic Shock, Shock, Toxic Trial in Manchester (hyperoncotic human albumin solution, Buffered crystalloid solutions)
Not yet recruiting
- Sepsis
- +2 more
- hyperoncotic human albumin solution
- Buffered crystalloid solutions
-
Manchester, Lancashire, United Kingdom
- +1 more
Jul 5, 2022
Spinal Diseases Trial (Desflurane Inhalation Solution, Sevoflurane Inhalation Solution)
Not yet recruiting
- Spinal Diseases
- Desflurane Inhalation Solution
- Sevoflurane Inhalation Solution
- (no location specified)
Nov 7, 2023